Patent · US Active

Macrocyclic pyridazinone derivatives

US10064861B2 · kind B2 · utility

4Cited by

0References

8Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Catherine Jorand-Lebrun · Arlington, US
Santosh S. Kulkarni · Kanchinakote, IN
Serge Christmann-Franck · Geneva, CH

Key dates

Filing date	Nov 30, 2016
Grant date	Sep 4, 2018
Priority date	—
Expiry date	Nov 30, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I) is provided: wherein R1, R2, R3, R4, L and Z have the meaning given in the claims. Further provided is the prophylaxis and treatment of diseases with the compound of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.